You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mogamulizumab

Showing 1 - 25 of 37
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cutaneous T Cell Lymphoma, Fungoides Mycosis Sezary Syndrome Trial in Ann Arbor (Pembrolizumab, Mogamulizumab)

Not yet recruiting
  • Cutaneous T Cell Lymphoma
  • Fungoides Mycosis Sezary Syndrome
  • Ann Arbor, Michigan
    University of Michigan Comprehensive Cancer Center
Jul 13, 2023

T Cell Lymphoma Trial in New Haven (Mogamulizumab, DA-EPOCH Protocol)

Not yet recruiting
  • T Cell Lymphoma
  • Mogamulizumab
  • DA-EPOCH Protocol
  • New Haven, Connecticut
    Yale Smilow Cancer Hospital
Aug 14, 2023

Cutaneous T Cell Lymphoma, Mycosis Fungoides Trial (Mogamulizumab, Brentuximab vedotin)

Not yet recruiting
  • Cutaneous T Cell Lymphoma
  • Mycosis Fungoides
  • Mogamulizumab
  • Brentuximab vedotin
  • (no location specified)
Dec 7, 2022

Sezary Syndrome, Mycosis Fungoides Trial in Stanford (Mogamulizumab, LD TSEBT)

Recruiting
  • Sezary Syndrome
  • Mycosis Fungoides
  • Mogamulizumab
  • LD TSEBT
  • Stanford, California
    Stanford Cancer Center
Oct 19, 2022

Folliculotropic Mycosis Fungoides, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Sezary Syndrome Trial in Duarte (procedure,

Active, not recruiting
  • Folliculotropic Mycosis Fungoides
  • +7 more
  • Extracorporeal Photopheresis
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Dec 8, 2022

Adult T-Cell Lymphoma/Leukemia, Sezary Syndrome, Mycosis Fungoides Trial run by the NCI (Recombinant human Interleukin-15

Completed
Has Results
  • Adult T-Cell Lymphoma/Leukemia
  • +2 more
  • Recombinant human Interleukin-15 (rhIL-15)
  • Mogamulizumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 9, 2022

Solid Tumor, Cancer, Carcinoma Trial in United States (Mogamulizumab + Nivolumab)

Completed
Has Results
  • Solid Tumor
  • +4 more
  • Mogamulizumab + Nivolumab
  • Gilbert, Arizona
  • +14 more
Jul 27, 2022

Mycosis Fungoides, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Sezary Syndrome Trial in Atlanta (procedure, biological,

Recruiting
  • Mycosis Fungoides
  • +2 more
  • Extracorporeal Photopheresis
  • +2 more
  • Atlanta, Georgia
    Emory University Hospital
Jun 15, 2022

Recurrent Adult T-Cell Leukemia/Lymphoma, Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Refractory Adult T-Cell

Recruiting
  • Recurrent Adult T-Cell Leukemia/Lymphoma
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Nov 18, 2022

Recurrent DLBCL, Recurrent High Grade B-Cell Lymphoma, Recurrent Transformed B-Cell Non-Hodgkin Lymphoma Trial in United States

Active, not recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma
  • +5 more
  • Mogamulizumab
  • Pembrolizumab
  • Sacramento, California
  • +7 more
Sep 15, 2022

Mycosis Fungoides, Recurrent Mycosis Fungoides, Recurrent Mycosis Fungoides and Sezary Syndrome Trial in United States

Recruiting
  • Mycosis Fungoides
  • +11 more
  • Biospecimen Collection
  • +5 more
  • Duarte, California
  • +12 more
Jan 7, 2023

Leukemia/Lymphoma Trial in Milwaukee

Active, not recruiting
  • Leukemia/Lymphoma
    • Milwaukee, Wisconsin
      CIBMTR
    Nov 17, 2021

    Cutaneous T-Cell Lymphoma, Relapsed, Cutaneous T-Cell Lymphoma Refractory Trial in Worldwide (Mogamulizumab)

    Recruiting
    • Cutaneous T-Cell Lymphoma, Relapsed
    • Cutaneous T-Cell Lymphoma Refractory
    • Mogamulizumab
    • Duarte, California
    • +17 more
    Jul 19, 2022

    Solid Tumor, Cancer, Carcinoma Trial in France, United States (KHK2455, Mogamulizumab)

    Completed
    • Solid Tumor
    • +2 more
    • Tampa, Florida
    • +3 more
    Aug 9, 2021

    Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma

    Not yet recruiting
    • Cutaneous T Cell Lymphoma
    • +2 more
      • Ancona, Italy
      • +19 more
      Nov 2, 2023

      Glioblastoma Multiforme Trial (KHK2455)

      No longer available
      • Glioblastoma Multiforme
      • (no location specified)
      Aug 9, 2021

      Advanced Solid Tumors, Metastatic Solid Tumors Trial in New York (Mogamulizumab (KW-0761))

      Completed
      Has Results
      • Advanced Solid Tumors
      • Metastatic Solid Tumors
      • Mogamulizumab (KW-0761)
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Mar 30, 2021

      Poteligeo in Adult Patients With MF and SS (PROSPER)

      Not yet recruiting
      • Mycosis Fungoides and Sézary Syndrome
      • Saint Louis, Missouri
      • +15 more
      Jul 8, 2022

      Gastric Cancer, Esophageal Cancer, Lung Cancer Trial in Suita (Mogamulizumab, Nivolumab)

      Completed
      • Gastric Cancer
      • +4 more
      • Mogamulizumab
      • Nivolumab
      • Suita, Osaka, Japan
        Osaka University
      Mar 4, 2020

      Cutaneous T-Cell Lymphoma Trial in Worldwide (KW-0761, Vorinostat)

      Completed
      Has Results
      • Cutaneous T-Cell Lymphoma
      • Birmingham, Alabama
      • +72 more
      Jul 22, 2022

      Solid Tumor Trial in Chiba, Tokyo (Mogamulizumab: KW-0761, Nivolumab: (ONO-4538/BMS-936558))

      Completed
      • Solid Tumor
      • Mogamulizumab: KW-0761, Nivolumab: (ONO-4538/BMS-936558)
      • Chiba, Japan
      • +1 more
      Jun 9, 2019

      NSCLC Trial in United States (mogamulizumab, Docetaxel)

      Completed
      Has Results
      • Non-Small Cell Lung Cancer
      • Lafayette, Indiana
      • +4 more
      Apr 24, 2018

      Advanced/Metastatic Solid Tumors Trial in United States (PF-05082566, KW-0761)

      Terminated
      Has Results
      • Advanced/Metastatic Solid Tumors
      • La Jolla, California
      • +20 more
      Feb 13, 2019

      Cutaneous T Cell Lymphoma, Peripheral T Cell Lymphoma Trial in Boston (Microdevices, Standard of care therapy, Standard of care

      Recruiting
      • Cutaneous T Cell Lymphoma
      • Peripheral T Cell Lymphoma
      • Microdevices
      • +2 more
      • Boston, Massachusetts
        Dana Farber Cancer Institute
      Jul 16, 2022

      Cancer Target Therapy Efficacy

      Active, not recruiting
      • Cancer
      • RNA sequencing
      • +5 more
      • Walnut, California
      • +6 more
      Sep 13, 2021